IRB Study Number 20-393
Status Recruiting
Institute Taussig Cancer Institute
Description
Develop a biorepository of blood and tissue samples from patients with DLBCL undergoing treatment to evaluate minimal residual disease and ctDNA.
Inclusion Criteria
DLBCL confirmed histologically
Age≥18 years old
Available blood and tissue samples from initial diagnosis
Exclusion Criteria
Inability to given consent
